Analyst Ratings for Regeneron Pharma (REGn)
REGn Rating Summary
REGn Price Target Summary
- Highest: $995.00 (Guggenheim)
- Lowest: $641.00 (Leerink)
- Average: $816.93
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$816.93 (+20.8%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/18/2026 | Leerink | Andrew Berens | Downgrade | Market Perform (Outperform) |
641.00 (N/A) |
698.25 (676.23) |
-3.15% | Details |
| 5/18/2026 | Citi | Geoff Meacham | Downgrade | Neutral (Buy) |
700.00 (900.00) |
712.87 (676.23) |
-5.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
